139 related articles for article (PubMed ID: 16434883)
1. Identification of novel targets of MYC whose transcription requires the essential MbII domain.
Zhang XY; DeSalle LM; McMahon SB
Cell Cycle; 2006 Feb; 5(3):238-41. PubMed ID: 16434883
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.
Zhang XY; DeSalle LM; Patel JH; Capobianco AJ; Yu D; Thomas-Tikhonenko A; McMahon SB
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13968-73. PubMed ID: 16172399
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
4. Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression.
Mu ZM; Yin XY; Prochownik EV
J Biol Chem; 2002 Nov; 277(45):43175-84. PubMed ID: 12196529
[TBL] [Abstract][Full Text] [Related]
5. MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.
Kalkat M; Resetca D; Lourenco C; Chan PK; Wei Y; Shiah YJ; Vitkin N; Tong Y; Sunnerhagen M; Done SJ; Boutros PC; Raught B; Penn LZ
Mol Cell; 2018 Dec; 72(5):836-848.e7. PubMed ID: 30415952
[TBL] [Abstract][Full Text] [Related]
6. An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
Kato GJ; Barrett J; Villa-Garcia M; Dang CV
Mol Cell Biol; 1990 Nov; 10(11):5914-20. PubMed ID: 2233723
[TBL] [Abstract][Full Text] [Related]
7. Skp2 regulates Myc protein stability and activity.
Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
[TBL] [Abstract][Full Text] [Related]
8. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Kidd M; Modlin IM; Pfragner R; Eick GN; Champaneria MC; Chan AK; Camp RL; Mane SM
Cancer; 2007 Jun; 109(12):2420-31. PubMed ID: 17469181
[TBL] [Abstract][Full Text] [Related]
9. Coordinated regulation of Myc trans-activation targets by Polycomb and the Trithorax group protein Ash1.
Goodliffe JM; Cole MD; Wieschaus E
BMC Mol Biol; 2007 May; 8():40. PubMed ID: 17519021
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of DNA replication licensing by Myc.
Valovka T; Schönfeld M; Raffeiner P; Breuker K; Dunzendorfer-Matt T; Hartl M; Bister K
Sci Rep; 2013 Dec; 3():3444. PubMed ID: 24309437
[TBL] [Abstract][Full Text] [Related]
11. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
12. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
13. N and C-terminal sub-regions in the c-Myc transactivation region and their joint role in creating versatility in folding and binding.
Fladvad M; Zhou K; Moshref A; Pursglove S; Säfsten P; Sunnerhagen M
J Mol Biol; 2005 Feb; 346(1):175-89. PubMed ID: 15663936
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression.
Mao DY; Watson JD; Yan PS; Barsyte-Lovejoy D; Khosravi F; Wong WW; Farnham PJ; Huang TH; Penn LZ
Curr Biol; 2003 May; 13(10):882-6. PubMed ID: 12747840
[TBL] [Abstract][Full Text] [Related]
15. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc.
Kurabe N; Katagiri K; Komiya Y; Ito R; Sugiyama A; Kawasaki Y; Tashiro F
Oncogene; 2007 Aug; 26(38):5626-34. PubMed ID: 17334388
[TBL] [Abstract][Full Text] [Related]
17. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity.
Wang YW; Chang HS; Lin CH; Yu WC
Int J Biochem Cell Biol; 2007; 39(2):402-12. PubMed ID: 17070091
[TBL] [Abstract][Full Text] [Related]
18. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif.
Thomas LR; Foshage AM; Weissmiller AM; Popay TM; Grieb BC; Qualls SJ; Ng V; Carboneau B; Lorey S; Eischen CM; Tansey WP
Oncogene; 2016 Jul; 35(27):3613-8. PubMed ID: 26522729
[TBL] [Abstract][Full Text] [Related]
19. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
